1. "2013"
  2. "Human Oncology and Pathogenesis Program"
Formats
  1. Journal Article (169)
  2. Meeting Abstract (134)
  3. Book Section (2)
  4. Book Whole (1)
  5. Conference Paper (1)
Groups
  1. Human Oncology and Pathogenesis Program (307)
  2. GSK Faculty (305)
  3. Department of Medicine (206)
  4. Tow Center for Developmental Oncology (TCDO) (126)
  5. Center for Hematologic Malignancies (112)
  6. Hematologic Malignancies, Division of (110)

More Groups

People
  1. Ross Levine (62)
  2. Marc Ladanyi (52)
  3. Michael Berger (43)
  4. Omar Abdel-Wahab (37)
  5. Jorge Reis-Filho (31)
  6. Nikolaus Schultz (26)

More People

Years
  1. 2013 (307)
Publications
  1. Blood (36)
  2. Journal of Clinical Oncology (28)
  3. Cancer Research (22)
  4. Modern Pathology (18)
  5. Laboratory Investigation (14)
  6. Journal of Thoracic Oncology (11)

More Publications

Publishers
  1. Nature Publishing Group (45)
  2. American Association for Cancer Research (39)
  3. American Society of Hematology (37)
  4. American Society of Clinical Oncology (28)
  5. Elsevier Inc. (20)
  6. Nature Research (18)

More Publishers

Results (307)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Indoleamine 2,3-dioxygenase is a critical resistance mechanism in anti-tumor T cell immunotherapy targeting CTLA-4
    Meeting Abstract

    Holmgaard, R. B.; Zamarin, D.; Munn, D. H.; Wolchok, J. D.; Allison, J. P.
    Journal for ImmunoTherapy of Cancer (2013)

    Fulltext@MSK | Save
  • Localized oncolytic virotherapy inflames distant tumors and synergizes with immune checkpoint blockade leading to systemic tumor rejection
    Meeting Abstract

    Zamarin, D.; Holmgaard, R.; Subudhi, S.; Mansour, M.; Palese, P.; Merghoub, T.; Wolchok, J. D.; Allison, J. P.
    Journal for ImmunoTherapy of Cancer (2013)

    Fulltext@MSK | Save
  • Molecular investigation of breast cancer
    Book Section

    Wilkerson, P. M.; Reis-Filho, J. S.
    In Benson, J. R.; Gui, G.; Tuttle, T. M. (Eds.) Early Breast Cancer: From Screening to Multidisciplinary Management. 3rd ed (2013)

    Fulltext@MSK | Save
  • Treatment outcome with mTOR inhibitors for 65 cases of non-clear cell renal cell carcinoma: Association of long-term responses and oncogenomic events
    Meeting Abstract

    Voss, M. H.; Bastos, D. A.; Karlo, C.; Patil, S.; Ajeti, A.; Hakimi, A. A.; Feldman, D. R.; Molina, A. M.; Berger, M. F.; Hsieh, J.; more...
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save
  • Prostate-specific mRNA detection in whole blood as an analytically validated prognostic biomarker for patients with castration-resistant prostate cancer (CRPC)
    Meeting Abstract

    Danila, D. C.; Anand, A.; Heller, G.; Wan, M.; Herkal, A.; Patel, C.; Khanin, R.; Schultz, N.; Lilja, H.; Fleisher, M.; more...
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save
  • Peroxisome proliferator-activated receptor gamma (PPARG) gene amplifications in urothelial carcinoma (UC)
    Meeting Abstract

    Bambury, R. M.; Iyer, G.; Riester, M.; Werner, L.; Schultz, N.; Stack, E. C.; Park, R.; Loda, M.; Ostrovnaya, I.; Kantoff, P. W.; more...
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save
  • Comparison of the characteristics and clinical course of 677 patients with metastatic lung cancers with mutations in KRAS codons 12 and 13
    Meeting Abstract

    Yu, H. A.; Sima, C. S.; Shen, R. L.; Kass, S. L.; Kris, M. G.; Ladanyi, M.; Riely, G. J.
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save
  • Phase II trial of the phosphatidyinositol-3 kinase (PI3K) inhibitor BKM120 in recurrent glioblastoma (GBM)
    Meeting Abstract

    Wen, P. Y.; Yung, W. K. A.; Mellinghoff, I. K.; Lamborn, K.; Ramkissoon, S.; Cloughesy, T. F.; Rinne, M.; Omuro, A. M. P.; DeAngelis, L. M.; Gilbert, M. R.; more...
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save
  • Genomic heterogeneity of circulating tumor cells in castration-resistant prostate cancer (CRPC) revealed by single-cell sequencing
    Meeting Abstract

    Welsh, A.; Danila, D. C.; Anand, A.; Kendall, J.; Sawyers, C. L.; Fleisher, M.; Wigler, M.; Hicks, J. B.; Scher, H. I.
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save
  • Effective monotherapy despite intratumor heterogeneity: Clonal convergence within the PI3K pathway and sensitivity to mTOR inhibitors in patients with advanced renal cell carcinoma (RCC)
    Meeting Abstract

    Voss, M. H.; Hakimi, A. A.; Chen, Y.; Pham, C. G.; Brannon, A. R.; Scott, S. N.; Takeda, S.; Liu, H.; Motzer, R. J.; Berger, M. F.; more...
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save